Statement for Appropriate Clinical Use of PCSK9 Inhibitors

Detalles Bibliográficos
Autores principales: Nohara, Atsushi, Ohmura, Hirotoshi, Okazaki, Hiroaki, Ogura, Masatsune, Kitagawa, Kazuo, Koseki, Masahiro, Sato, Kayoko, Tsukamoto, Kazuhisa, Yamashita, Shizuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2018
Materias:
Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099074/
https://www.ncbi.nlm.nih.gov/pubmed/29899173
http://dx.doi.org/10.5551/jat.45229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099074/
https://www.ncbi.nlm.nih.gov/pubmed/29899173
http://dx.doi.org/10.5551/jat.45229

Ejemplares similares